Browse EX-10 agreements

** **

Exhibit 10.7

Execution Version (2)

Agreement

With respect to

Compensation and Other Arrangements

THIS AGREEMENT, made as of April 1, 2026 (the “Effective Date”), is made by and among Leonard Osser, residing at 32 Camlet Court, Roseland, New Jersey 07068 (“Executive”), U.S. Asian Consulting Group, LLC, a Delaware limited liability company (“U.S. Asian”), and Milestone Scientific, Inc., a Delaware corporation having its office at 425 Eagle Rock Avenue, Suite 403, Roseland, New Jersey 07068 (the “Company” and, together with Executive and U.S Asian, each “Party” and collectively, the “Parties”).

RECITALS

A. Executive is a principal and together with his wife the sole members of U.S. Asian; and

B. The Company and Executive entered into an Employment Agreement dated July 11, 2017 (the “Employment Agreement”), and the Company and U.S. Asian entered into a Consulting Agreement dated July 10, 2017 (the “Consulting Agreement”); and

…

June 30, 2026 Ameet Mallik 84 Garfield Ave Madison, NJ 07940 Dear Ameet, ADC Therapeutics, Inc. (the “Company”) is pleased to offer you this Incentive Award Letter Agreement. The Company values your continued contributions to its business and wishes to incentivize you to remain employed by the Company. Subject to the terms and conditions set forth herein, the Company will pay you a cash incentive award in the amount of $1,795,500 (the “Cash Incentive Award”) and you will be granted an award of 675,000 restricted stock units (the “RSU Award,” together with the Cash Incentive Award, the “Incentive Awards”). 1. The Cash Incentive Award shall be subject to the terms and conditions set forth below: (a) The Cash Incentive Award will be paid to you on or about July 15, 2026. (b) To be eligible to retain the Cash Incentive Award, you must continue to perform the duties specified in the Employment Agreement between you and the Company, dated December 20, 2023 (the “Employment Agreement”) and otherwise reasonably assigned to you by the Board of Directors in a satisfactory manner and in complia

…

June 30, 2026 Mohamed Zaki 2501 Washington Lane Bethlehem, PA 18015 Dear Mohamed, ADC Therapeutics, Inc. (the “Company”) is pleased to offer you this Incentive Award Letter Agreement. The Company values your continued contributions to its business and wishes to incentivize you to remain employed by the Company. Subject to the terms and conditions set forth herein, the Company will pay you a cash incentive award in the amount of $568,974 (the “Cash Incentive Award”) and you will be granted an award of 213,900 restricted stock units (the “RSU Award,” together with the Cash Incentive Award, the “Incentive Awards”). 1. The Cash Incentive Award shall be subject to the terms and conditions set forth below: (a) The Cash Incentive Award will be paid to you on or about July 15, 2026. (b) To be eligible to retain the Cash Incentive Award, you must continue to perform the duties specified in the Employment Agreement between you and the Company, dated December 22, 2023 (the “Employment Agreement”) and otherwise reasonably assigned to you by the Board of Directors in a satisfactory manner and in

…

June 30, 2026 Pepe Carmona 721 Thomas Road Philadelphia, PA 19118 Dear Pepe, ADC Therapeutics, Inc. (the “Company”) is pleased to offer you this Incentive Award Letter Agreement. The Company values your continued contributions to its business and wishes to incentivize you to remain employed by the Company. Subject to the terms and conditions set forth herein, the Company will pay you a cash incentive award in the amount of $541,842 (the “Cash Incentive Award”) and you will be granted an award of 203,700 restricted stock units (the “RSU Award,” together with the Cash Incentive Award, the “Incentive Awards”). 1. The Cash Incentive Award shall be subject to the terms and conditions set forth below: (a) The Cash Incentive Award will be paid to you on or about July 15, 2026. (b) To be eligible to retain the Cash Incentive Award, you must continue to perform the duties specified in the Employment Agreement between you and the Company, dated December 22, 2023 (the “Employment Agreement”) and otherwise reasonably assigned to you by the Board of Directors in a satisfactory manner and in compl

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE COMPANY TREATS AS PRIVATE OR CONFIDENTIAL.

LOAN AND SECURITY AGREEMENT

THIS LOAN AND SECURITY AGREEMENT is made and dated as of June 24, 2026 and is entered into by and among 4D MOLECULAR THERAPEUTICS, INC., a Delaware corporation (“Company”), and each other Person that has delivered a Joinder Agreement pursuant to Section 7.13from time to time party hereto (together with Company, individually or collectively, as the context may require, “Borrower”), the several banks and other financial institutions or entities from time to time party hereto (each, a “Lender”, and collectively “Lenders”) and HERCULES CAPITAL, INC., a Maryland corporation, in its capacity as administrative agent and collateral agent for itself and Lenders (in such capacity, including any successors or assigns, “Agent”).

RECITALS

…

…

2025 STOCK OPTION AND INCENTIVE PLAN

I. GENERAL

…

DATE 6**th May 2026**

**NORBROOK LABORATORIES LIMITED **

AND

IMMUCELL CORPORATION

SETTLEMENT DEED

---

THIS SETTLEMENT DEED is made on 6**th May 2026**

BETWEEN

1.	**NORBROOK LABORATORIES LIMITED **(company registration number NI007665) whose registered office is at Station Works, Camlough Road, Newry, Co. Down, Northern Ireland, BT35 6JP (“Norbrook”); and

…

**FIRST AMENDMENT **

TO THE

INFRARED CAMERAS HOLDINGS, INC. 2023 INCENTIVE AWARD PLAN

This FIRST AMENDMENT TO THE INFRARED CAMERAS HOLDINGS, INC. 2023 INCENTIVE AWARD PLAN (this “Amendment”), effective as of June 4, 2025, is made and entered into by MultiSensor AI Holdings, Inc. (f/k/a, Infrared Cameras Holdings, Inc.), a Delaware corporation (the “Company”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Infrared Cameras Holdings, Inc. 2023 Incentive Award Plan (the “Plan”).

RECITALS

WHEREAS, Section 10.4 of the Plan provides that the Board of Directors of the Company (the “Board”) may amend the Plan at any time and from time to time;

WHEREAS, the Board desires to amend the Plan to increase the aggregate number of shares of Common Stock that may be issued under the Plan as set forth in Section 11.24 of the Plan by an additional three million, four hundred thousand (3,400,000) shares of Common Stock; and

…

Limited Waiver, Consent, and Amendment No. 3 to Credit Agreement

This LIMITED WAIVER, CONSENT, AND AMENDMENT NO. 3 TO CREDIT AGREEMENT dated as of August 6, 2026 (this “Consent and Amendment”), is among SOLUNA DVSL COMPUTECO, LLC, a Delaware limited liability company (“Dorothy 1A Borrower”), SOLUNA DVSL II COMPUTECO, LLC, a Delaware limited liability company (“Dorothy 2 Borrower”), SOLUNA KK I COMPUTECO LLC, a Delaware limited liability company (the “Tranche B Borrower”), and SOLUNA DV WIND SPONSORCO, LLC, a Delaware limited liability company (the “Tranche C Borrower”, and together with the Dorothy 1A Borrower, the Dorothy 2 Borrower and the Tranche B Borrower, the “Borrowers”); and GENERATE LENDING, LLC, as administrative agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, the “Administrative Agent”) and as collateral agent for the Secured Parties (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”, and together with the Administrative Agent, collectively, the “Agents” and each an “Agen

…

					OptimizeRx Corporation260 Charles Street, Suite 302Waltham, MA 02453

May 11, 2026

Theresa Greco

[XXXX]

[XXXX]

RE: Separation Agreement and Release of Claims; Advisory Terms & Conditions

Dear Theresa,

…

---

Exhibit 10.3

Executive Employment Agreement

THIS EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement")is made effective as of the 30th day of June 2026 (the "Effective Date"), by and between Nuwellis, Inc., a Delaware corporation (the "Company")and Michael K. McCormick (the "Executive")

Recitals

Whereas, the Board of Directors of the Company (the "Board")has determined that it is in the best interests of the Company and its stockholders to employ the Executive as of the Effective Date;

Whereas, the Company and the Executive desire to enter into this Agreement to embody the terms of the Executive's employment relationship; and

Whereas, this Agreement shall represent the entire understanding and agreement between the parties with respect to the Executive's employment with the Company.

Agreement

Now, Therefore, in consideration of the foregoing and the terms and conditions set forth herein, the parties agree as follows:

1.

…